Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;58(12):2239-2254.
doi: 10.1194/jlr.R075630. Epub 2017 Mar 15.

Cellular cholesterol homeostasis and Alzheimer's disease

Affiliations
Review

Cellular cholesterol homeostasis and Alzheimer's disease

Ta-Yuan Chang et al. J Lipid Res. 2017 Dec.

Abstract

Alzheimer's disease (AD) is the most common form of dementia in older adults. Currently, there is no cure for AD. The hallmark of AD is the accumulation of extracellular amyloid plaques composed of amyloid-β (Aβ) peptides (especially Aβ1-42) and neurofibrillary tangles, composed of hyperphosphorylated tau and accompanied by chronic neuroinflammation. Aβ peptides are derived from the amyloid precursor protein (APP). The oligomeric form of Aβ peptides is probably the most neurotoxic species; its accumulation eventually forms the insoluble and aggregated amyloid plaques. ApoE is the major apolipoprotein of the lipoprotein(s) present in the CNS. ApoE has three alleles, of which the Apoe4 allele constitutes the major risk factor for late-onset AD. Here we describe the complex relationship between ApoE4, oligomeric Aβ peptides, and cholesterol homeostasis. The review consists of four parts: 1) key elements involved in cellular cholesterol metabolism and regulation; 2) key elements involved in intracellular cholesterol trafficking; 3) links between ApoE4, Aβ peptides, and disturbance of cholesterol homeostasis in the CNS; 4) potential lipid-based therapeutic targets to treat AD. At the end, we recommend several research topics that we believe would help in better understanding the connection between cholesterol and AD for further investigations.

Keywords: ATP binding cassette transporter A1; acyl-coenzyme A:cholesterol acyltransferase; aging; amyloidopathy; apolipoprotein E; brain lipids; cholesterol metabolism; lipid raft; lipid trafficking; membrane contact sites; tauopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Chemical structures of cholesterol and its various metabolites. This figure is reprinted from Ref. .
Fig. 2.
Fig. 2.
Cellular cholesterol trafficking. The movement of cholesterol among various subcellular compartments is governed by at least three distinct metabolic pathways, resulting in three major cholesterol pools that are not in rapid equilibration with one another. The dotted lines represent cholesterol trafficking steps not well-documented at present. See the text for details. EE, early endosome; ERC, endocytic recycling compartment.
Fig. 3.
Fig. 3.
A working model to describe the ApoE-mediated cholesterol homeostasis in astrocytes and neurons. The dotted lines represent sterol trafficking steps that are not well-documented at present. See the text for details. NR, nuclear receptor.
Fig. 4.
Fig. 4.
Beneficial effects of ACAT1SOAT1 blockage on amyloidopathy and on tauopathy. In neurons, ACAT1SOAT1 blockage results in reduced full-length human APP content that leads to less Aβ production; ACAT1SOAT1 blockage also results in reduced protein content of the non-hyper-phosphorylated tau. In microglia, ACAT1SOAT1 blockage increases Aβ clearance. See text and (224) for details.

Similar articles

Cited by

References

    1. Bloch K. 1965. The biological synthesis of cholesterol. Science. 150: 19–28. - PubMed
    1. Porter F. D., and Herman G. E.. 2011. Malformation syndromes caused by disorders of cholesterol synthesis. J. Lipid Res. 52: 6–34. - PMC - PubMed
    1. Nes W. D. 2011. Biosynthesis of cholesterol and other sterols. Chem. Rev. 111: 6423–6451. - PMC - PubMed
    1. Jo Y., and Debose-Boyd R. A.. 2010. Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. Crit. Rev. Biochem. Mol. Biol. 45: 185–198. - PMC - PubMed
    1. Burg J. S., and Espenshade P. J.. 2011. Regulation of HMG-CoA reductase in mammals and yeast. Prog. Lipid Res. 50: 403–410. - PMC - PubMed

Publication types

MeSH terms